This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, Y.
Right arrow Articles by Cutler, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, Y.
Right arrow Articles by Cutler, J. E.

 Previous Article  |  Next Article 

Infection and Immunity, December 1998, p. 5771-5776, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance to Candida albicans Vaginal Infection

Yongmoon Han, Richard P. Morrison, and Jim E. Cutler*

Department of Microbiology, Montana State University, Bozeman, Montana 59717-3520

Received 13 July 1998/Returned for modification 18 August 1998/Accepted 8 September 1998

We previously reported that a vaccine composed of liposome-mannan complexes of Candida albicans (L-mann) stimulates mice to produce protective antibodies against disseminated candidiasis. An immunoglobulin M (IgM) monoclonal antibody (MAb), B6.1, specific for a beta -1,2-mannotriose in the complexes protects against the disease, whereas MAb B6 does not. In the present study, the vaccine and MAbs B6.1 and B6 were tested for the ability to protect against Candida vaginal infection, established by intravaginal (i.vg.) inoculation of yeast cells in mice maintained in pseudoestrus. Fungal CFU in each vagina was determined to assess the severity of infection. Mice vaccinated before infection developed about 62% fewer vaginal CFU than nonimmunized controls. Naive mice that received polyclonal antiserum (from vaccinated mice) i.vg. before infection had 60% fewer CFU than controls. The serum protective factor was stable at 56°C, but C. albicans cells absorbed this factor. Mice given MAb B6.1 i.vg. after infection was established had fewer Candida CFU in vaginal tissue than control mice given buffer instead of antibody. MAbs B6.1 and B6 given intraperitoneally before infection protected mice, but MAbs preabsorbed with yeast cells did not. MAb B6.1 also protected against C. tropicalis vaginal infection, but MAb B6 did not. The protective activities of MAbs B6.1 and B6 appeared to be specific because an irrelevant IgM carbohydrate-specific MAb and an irrelevant IgG protein-specific MAb were not protective; also, MAb B6.1 did not affect development of vaginal chlamydial infection. These studies show that an appropriate antibody response, or administration of protective antibodies, can help the host to resist Candida vaginal infection.

* Corresponding author. Mailing address: Montana State University, Department of Microbiology, Lewis Hall 109, P.O. Box 173520, Bozeman, MT 59717-3520. Phone: (406) 994-2373. Fax: (406) 994-4926. E-mail: umbjc{at}montana.edu.

Infection and Immunity, December 1998, p. 5771-5776, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Fradin, C., Slomianny, M. C., Mille, C., Masset, A., Robert, R., Sendid, B., Ernst, J. F., Michalski, J. C., Poulain, D. (2008). {beta}-1,2 Oligomannose Adhesin Epitopes Are Widely Distributed over the Different Families of Candida albicans Cell Wall Mannoproteins and Are Associated through both N- and O-Glycosylation Processes. Infect. Immun. 76: 4509-4517 [Abstract] [Full Text]  
  • Xin, H., Dziadek, S., Bundle, D. R., Cutler, J. E. (2008). Synthetic glycopeptide vaccines combining {beta}-mannan and peptide epitopes induce protection against candidiasis. Proc. Natl. Acad. Sci. USA 105: 13526-13531 [Abstract] [Full Text]  
  • Cambi, A., Netea, M. G., Mora-Montes, H. M., Gow, N. A. R., Hato, S. V., Lowman, D. W., Kullberg, B.-J., Torensma, R., Williams, D. L., Figdor, C. G. (2008). Dendritic Cell Interaction with Candida albicans Critically Depends on N-Linked Mannan. J. Biol. Chem. 283: 20590-20599 [Abstract] [Full Text]  
  • Casadevall, A., Pirofski, L.-a. (2007). Antibody-Mediated Protection through Cross-Reactivity Introduces a Fungal Heresy into Immunological Dogma. Infect. Immun. 75: 5074-5078 [Full Text]  
  • Cassone, A., De Bernardis, F., Santoni, G. (2007). Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention. Infect. Immun. 75: 4675-4686 [Full Text]  
  • Khot, P. D., Suci, P. A., Miller, R. L., Nelson, R. D., Tyler, B. J. (2006). A Small Subpopulation of Blastospores in Candida albicans Biofilms Exhibit Resistance to Amphotericin B Associated with Differential Regulation of Ergosterol and {beta}-1,6-Glucan Pathway Genes. Antimicrob. Agents Chemother. 50: 3708-3716 [Abstract] [Full Text]  
  • Xin, H., Cutler, J. E. (2006). Hybridoma Passage In Vitro May Result in Reduced Ability of Antimannan Antibody To Protect against Disseminated Candidiasis. Infect. Immun. 74: 4310-4321 [Abstract] [Full Text]  
  • Sevilla, M. J., Robledo, B., Rementeria, A., Moragues, M. D., Ponton, J. (2006). A Fungicidal Monoclonal Antibody Protects against Murine Invasive Candidiasis.. Infect. Immun. 74: 3042-3045 [Abstract] [Full Text]  
  • Chaturvedi, A. K., Kavishwar, A., Shiva Keshava, G. B., Shukla, P. K. (2005). Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine Aspergillosis. CVI 12: 1063-1068 [Abstract] [Full Text]  
  • Singleton, D. R., Masuoka, J., Hazen, K. C. (2005). Surface Hydrophobicity Changes of Two Candida albicans Serotype B mnn4{Delta} Mutants. Eukaryot Cell 4: 639-648 [Abstract] [Full Text]  
  • Mille, C., Janbon, G., Delplace, F., Ibata-Ombetta, S., Gaillardin, C., Strecker, G., Jouault, T., Trinel, P.-A., Poulain, D. (2004). Inactivation of CaMIT1 Inhibits Candida albicans Phospholipomannan {beta}-Mannosylation, Reduces Virulence, and Alters Cell Wall Protein {beta}-Mannosylation. J. Biol. Chem. 279: 47952-47960 [Abstract] [Full Text]  
  • Hurd, E. A., Domino, S. E. (2004). Increased Susceptibility of Secretor Factor Gene Fut2-Null Mice to Experimental Vaginal Candidiasis. Infect. Immun. 72: 4279-4281 [Abstract] [Full Text]  
  • de Mattos Grosso, D., de Almeida, S. R., Mariano, M., Lopes, J. D. (2003). Characterization of gp70 and Anti-gp70 Monoclonal Antibodies in Paracoccidioides brasiliensis Pathogenesis. Infect. Immun. 71: 6534-6542 [Abstract] [Full Text]  
  • Moragues, M. D., Omaetxebarria, M. J., Elguezabal, N., Sevilla, M. J., Conti, S., Polonelli, L., Ponton, J. (2003). A Monoclonal Antibody Directed against a Candida albicans Cell Wall Mannoprotein Exerts Three Anti-C. albicans Activities. Infect. Immun. 71: 5273-5279 [Abstract] [Full Text]  
  • Naglik, J. R., Challacombe, S. J., Hube, B. (2003). Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis. Microbiol. Mol. Biol. Rev. 67: 400-428 [Abstract] [Full Text]  
  • Mondello, F., De Bernardis, F., Girolamo, A., Salvatore, G., Cassone, A. (2003). In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 51: 1223-1229 [Abstract] [Full Text]  
  • Tavares, D., Ferreira, P., Arala-Chaves, M. (2003). Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Microbiology 149: 333-339 [Abstract] [Full Text]  
  • Dromer, F., Chevalier, R., Sendid, B., Improvisi, L., Jouault, T., Robert, R., Mallet, J. M., Poulain, D. (2002). Synthetic Analogues of {beta}-1,2 Oligomannosides Prevent Intestinal Colonization by the Pathogenic Yeast Candida albicans. Antimicrob. Agents Chemother. 46: 3869-3876 [Abstract] [Full Text]  
  • Suci, P. A., Tyler, B. J. (2002). Action of Chlorhexidine Digluconate against Yeast and Filamentous Forms in an Early-Stage Candida albicans Biofilm. Antimicrob. Agents Chemother. 46: 3522-3531 [Abstract] [Full Text]  
  • Bromuro, C., Torosantucci, A., Chiani, P., Conti, S., Polonelli, L., Cassone, A. (2002). Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of a Candida albicans Vaccine. Infect. Immun. 70: 5462-5470 [Abstract] [Full Text]  
  • Wozniak, K. L., Wormley, F. L. Jr., Fidel, P. L. Jr. (2002). Candida-Specific Antibodies during Experimental Vaginal Candidiasis in Mice. Infect. Immun. 70: 5790-5799 [Abstract] [Full Text]  
  • Poulain, D., Slomianny, C., Jouault, T., Gomez, J. M., Trinel, P. A. (2002). Contribution of Phospholipomannan to the Surface Expression of {beta}-1,2-Oligomannosides in Candida albicans and Its Presence in Cell Wall Extracts. Infect. Immun. 70: 4323-4328 [Abstract] [Full Text]  
  • De Bernardis, F., Boccanera, M., Adriani, D., Girolamo, A., Cassone, A. (2002). Intravaginal and Intranasal Immunizations Are Equally Effective in Inducing Vaginal Antibodies and Conferring Protection against Vaginal Candidiasis. Infect. Immun. 70: 2725-2729 [Abstract] [Full Text]  
  • Torosantucci, A., Chiani, P., De Bernardis, F., Cassone, A., Calera, J. A., Calderone, R. (2002). Deletion of the Two-Component Histidine Kinase Gene (CHK1) of Candida albicans Contributes to Enhanced Growth Inhibition and Killing by Human Neutrophils In Vitro. Infect. Immun. 70: 985-987 [Abstract] [Full Text]  
  • Jouault, T., Fradin, C., Dzierszinski, F., Borg-Von-Zepelin, M., Tomavo, S., Corman, R., Trinel, P.-A., Kerckaert, J.-P., Poulain, D. (2001). Peptides that mimic Candida albicans-derived {beta}-1,2-linked mannosides. Glycobiology 11: 693-701 [Abstract] [Full Text]  
  • Han, Y., Kozel, T. R., Zhang, M. X., MacGill, R. S., Carroll, M. C., Cutler, J. E. (2001). Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis. J. Immunol. 167: 1550-1557 [Abstract] [Full Text]  
  • Viudes, A., Perea, S., Lopez-Ribot, J. L. (2001). Identification of Continuous B-Cell Epitopes on the Protein Moiety of the 58-Kilodalton Cell Wall Mannoprotein of Candida albicans Belonging to a Family of Immunodominant Fungal Antigens. Infect. Immun. 69: 2909-2919 [Abstract] [Full Text]  
  • Hazen, K. C., Wu, J. G., Masuoka, J. (2001). Comparison of the Hydrophobic Properties of Candida albicans and Candida dubliniensis. Infect. Immun. 69: 779-786 [Abstract] [Full Text]  
  • de Bernardis, F., Santoni, G., Boccanera, M., Spreghini, E., Adriani, D., Morelli, L., Cassone, A. (2000). Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection against Candida albicans. Infect. Immun. 68: 3297-3304 [Abstract] [Full Text]  
  • Han, Y., Riesselman, M. H., Cutler, J. E. (2000). Protection against Candidiasis by an Immunoglobulin G3 (IgG3) Monoclonal Antibody Specific for the Same Mannotriose as an IgM Protective Antibody. Infect. Immun. 68: 1649-1654 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»